YMAB

Y-mAbs Therapeutics
YMAB

Delisted

YMAB was delisted on the 15th of September, 2025.

Back to rankings

37 hedge funds and large institutions have $205M invested in Y-mAbs Therapeutics in 2018 Q3 according to their latest regulatory filings, with 37 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

Holders
37
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$55.9M
2
+$42.2M
3
+$32.7M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$10.3M
5
AllianceBernstein
AllianceBernstein
Tennessee
+$8.63M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$55.9M
2
$42.2M
3
$32.7M
4
$10.3M
5
$8.63M
6
$8.5M
7
$8.27M
8
$8.23M
9
$5.31M
10
$3.98M
11
$3.98M
12
$3.32M
13
$2.26M
14
$1.8M
15
$1.56M
16
$1.33M
17
$1.06M
18
$798K
19
$664K
20
$664K
21
$594K
22
$486K
23
$398K
24
$398K
25
$398K
1
2